Company Filing History:
Years Active: 2008
Title: Aniruddha Datta: Innovator in Pharmaceutical Compositions
Introduction: Aniruddha Datta is a notable inventor based in New Delhi, India, who has made significant contributions to the field of pharmaceuticals. With a focus on innovative compositions for treating various anorectal and colonic diseases, Dr. Datta's work showcases the intersection of research and practical application in medicine.
Latest Patents: Aniruddha Datta holds one patent that pertains to unique compositions derived from plant extracts. These compositions are formulated with pharmaceutically acceptable carriers and, optionally, additional therapeutic agents. Specifically designed for the treatment of conditions such as hemorrhoids, fissures, cracks, fistulas, abscesses, and inflammatory bowel disease, this invention possesses essential properties to control inflammation and prevent capillary bleeding in mammals, particularly in human beings. The compositions include flavonoidal and phenolic constituents, known for their anti-inflammatory, analgesic, haemostatic, and wound-healing properties.
Career Highlights: Dr. Datta is affiliated with Panacea Biotec Limited, a prominent pharmaceutical company known for its commitment to research and development. His involvement in this organization demonstrates his dedication to creating solutions that address pressing medical issues through innovative approaches.
Collaborations: Throughout his career, Aniruddha Datta has collaborated with notable colleagues such as Rajesh Jain and Kour Chand Jindal. These partnerships highlight the collaborative spirit in the field of pharmaceutical research, fostering an environment of innovation and shared expertise.
Conclusion: Aniruddha Datta's contributions as an inventor are noteworthy, particularly in the realm of pharmaceutical compositions aimed at treating anorectal and colonic diseases. His innovative solutions and collaborative efforts reflect his commitment to advancing medical science, ultimately leading to better health outcomes for patients.